Price range: $36.00 through $59.00 / 10 Vials
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide known for its remarkable ability to promote and regulate high-quality deep sleep. By targeting the delta-wave sleep patterns, it helps restore the body’s natural circadian rhythm without the grogginess or dependency associated with pharmacological sedatives. Beyond sleep, DSIP is extensively researched for its role in stress reduction, hormonal balance, and its potential to act as a powerful antioxidant within the central nervous system.
Amino Acid Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Molecular Formula$C_{35}H_{48}N_{10}O_{15}$
Molecular Weight 848.8 g/mol
PubChem CID 65053
CAS Number 62568-57-4
Vial Size 3ml (or standard 2ml/5ml vials)
Contents Lyophilized powder, white/off-white color
| Size | 5mg, 2mg |
|---|---|
| Mechanism of Action | Delta-Wave Promotion: DSIP selectively modulates the sleep-wake cycle by increasing the duration and intensity of delta $(\delta)$ oscillations in the brain, which are characteristic of the deepest, most restorative stages of sleep.Stress Response Modulation: It helps lower basal cortisol levels and regulates the HPA axis (Hypothalamic-Pituitary-Adrenal), making the body more resilient to physiological and emotional stress.Hormonal Regulation: Research indicates that DSIP can influence the release of other key hormones, such as Luteinizing Hormone (LH) and Somatotropin (GH), supporting overall endocrine health.Neuroprotection & Antioxidant: It exhibits the ability to reduce oxidative damage and inhibit lipid peroxidation, protecting neurons during periods of metabolic stress. |
| Storage & handling | Storage:Store the lyophilized vial in a cool, dry area protected from direct sunlight. |
All products on this site are for laboratory research, development, or analytical use only; they are NOT FOR HUMAN CONSUMPTION, medical, diagnostic, cosmetic, or veterinary applications.
These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat, or prevent any disease. Genixpep is not a compounding or outsourcing facility under sections 503A/503B of the FD&C Act.
